Rafał Wolny (@rafalwolny) 's Twitter Profile
Rafał Wolny

@rafalwolny

MD, PhD, interventional and imaging cardiologist; husband and father; National Institute of Cardiology. Tweets = own.

ID: 2285678581

calendar_today10-01-2014 21:37:53

498 Tweet

598 Followers

484 Following

Rafał Wolny (@rafalwolny) 's Twitter Profile Photo

Pleased to share our research from Narodowy Instytut Kardiologii on the CT-derived PCAT in SCAD published in Heart_BMJ. Thanks to Damini Dey for great support. Anyone interested who doesn't have full text access - please DM me. European Society of Cardiology Polskie Towarzystwo Kardiologiczne @HeartSCCT #yescct heart.bmj.com/content/early/…

Polish Heart Journal (@heart_polish) 's Twitter Profile Photo

Dear Authors, Reviewers, and Readers, We are pleased to announce that the 2022 Impact Factor of #PolishHeartJournal is 3.3. We express our deepest gratitude to the authors, reviewers, and editors who have contributed to this achievement. Thank you! Editorial Team

Dear Authors, Reviewers, and Readers,

We are pleased to announce that the 2022 Impact Factor of #PolishHeartJournal is 3.3. 

We express our deepest gratitude to the authors, reviewers, and editors who have contributed to this achievement. Thank you!

Editorial Team
Quynh Truong (@cardioqt) 's Twitter Profile Photo

Pls retweet.  If you are a super star, join us!     Division of Cardiology at NYP-Weill Cornell Medicine is looking to expand & hire cardiologists in imaging and non-imaging at all career levels. Weill Cornell Medicine    Send your CV to Jonathan Weinsaft  [email protected]  1/🧵⏭️

Maciej Banach (@maciejbanach) 's Twitter Profile Photo

Today I have consulted another (!) #patient with phenotypically diagnosed #Familial #Hypercholesterolemia - man at the age of 45, with levels of #LDLC between 239 to 315 mg/dl in last 5 years, who was terrified of these results by himself, and in last several years was going from

Today I have consulted another (!) #patient with phenotypically diagnosed #Familial #Hypercholesterolemia - man at the age of 45, with levels of #LDLC between 239 to 315 mg/dl in last 5 years, who was terrified of these results by himself, and in last several years was going from
Porozumienie Rezydentów OZZL (@rezydenci) 's Twitter Profile Photo

‼️ Wiele wydarzyło się w ochronie zdrowia podczas ostatnich dni. Sytuacja jest napięta już od ponad miesiąca. 🗓️ Wszystko zaczęło się 30 czerwca kiedy to Minister Niedzielski zwołał o konferencję prasową. Ogłosił, że z uwagi na nieumiejętność środowiska lekarskiego podejmie

‼️ Wiele wydarzyło się w ochronie zdrowia podczas ostatnich dni. Sytuacja jest napięta już od ponad miesiąca. 

🗓️ Wszystko zaczęło się 30 czerwca kiedy to Minister Niedzielski zwołał o konferencję prasową. Ogłosił, że z uwagi na nieumiejętność środowiska lekarskiego podejmie
Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

Breaking news from Novo Nordisk. In the randomized, double-blind SELECT trial, semaglutide 2.4 mg as an adjunct to standard of care reduced MACE by 20% in 17,604 adults with established CVD with overweight or obesity and without prior history of diabetes. Let's wait for the NNT.

Breaking news from Novo Nordisk. In the randomized, double-blind SELECT trial, semaglutide 2.4 mg as an adjunct to standard of care reduced MACE by 20% in 17,604 adults with established CVD with overweight or obesity and without prior history of diabetes. Let's wait for the NNT.
Sebastian Goncerz (@s_goncerz) 's Twitter Profile Photo

Chcemy jakości w kształceniu, jakości w pracy i jakosci w systemie. Jesli decydenci nie słyszą tego w naszych pismach i apelach to usłyszą na ulicach. Do zobaczenia w Warszawie!

NEJM (@nejm) 's Twitter Profile Photo

In patients w/ cardiovascular disease & overweight or obesity but no diabetes, semaglutide was superior to placebo in lowering the risk of major adverse cardiovascular events at a mean follow-up of 39.8 mos. Full SELECT trial results: nej.md/465pj91 #AHA23 AHA Science

Tomasz Leleno (@tleleno) 's Twitter Profile Photo

🩺👨‍⚕️Zespół kardiologów interwencyjnych z Narodowy Instytut Kardiologii przeprowadził pierwsze w województwie mazowieckim cztery zabiegi przezcewnikowego zwężenia zatoki wieńcowej (tzw. implantacja „sinus reducer”). Więcej👇👉tiny.pl/ckll7 #kardiologia #pacjenci #zdrowie

🩺👨‍⚕️Zespół kardiologów interwencyjnych z <a href="/nikardiologii/">Narodowy Instytut Kardiologii</a> przeprowadził pierwsze w województwie mazowieckim cztery zabiegi przezcewnikowego zwężenia zatoki wieńcowej (tzw. implantacja „sinus reducer”). Więcej👇👉tiny.pl/ckll7
#kardiologia #pacjenci #zdrowie
Maksymilian Opolski (@opolskimp) 's Twitter Profile Photo

See the key findings from our study on stress in CTO PCI: 1️⃣ HR&BP in CTO PCI ⬆️ than during regular work/non-CTO procedures 2️⃣ HR ↗️ relative to CTO PCI duration 3️⃣ HR in CTO PCI ⬆️ than in STEMI PCI 4️⃣ HR highest in failed CTO PCI JACC Journals TCTMD sciencedirect.com/science/articl…

NEJM (@nejm) 's Twitter Profile Photo

Presented at #ACC24: Hospitalized patients with acute myocardial infarction & preserved EF were assigned to receive open-label long-term beta-blocker therapy or not. Beta-blockers did not lead to a lower risk of death or MI. Full REDUCE-AMI trial results: nej.md/4akVhRx

Presented at #ACC24:

Hospitalized patients with acute myocardial infarction &amp; preserved EF were assigned to receive open-label long-term beta-blocker therapy or not. Beta-blockers did not lead to a lower risk of death or MI. Full REDUCE-AMI trial results: nej.md/4akVhRx
EAPCIPresident (@eapcipresident) 's Twitter Profile Photo

First-ever open call to ALL #EAPCI Members for positions on the upcoming #EAPCI Committees 2024-2026 ‼️ APPLY NOW to shape the future of #IC and #EAPCI: 🔗bit.ly/EAPCIcall Take 3-5 minutes to fill in the form👇 YOU ARE #EAPCI🫵

Rafał Wolny (@rafalwolny) 's Twitter Profile Photo

While the non-invasive characterization of atherosclerosis is rapidly evolving, it is my pleasure to share with you our hot-off-the-press review in Current Atherosclerosis Reports. Thank you Damini Dey and all co-authors! Full text: rdcu.be/dHBVL

While the non-invasive characterization of atherosclerosis is rapidly evolving, it is my pleasure to share with you our hot-off-the-press review in Current Atherosclerosis Reports. Thank you <a href="/damini_dey/">Damini Dey</a> and all co-authors! Full text: rdcu.be/dHBVL